Loading...
Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1
To improve the efficacy of immunotherapy for cancer and autoimmune diseases, recent ongoing and completed clinical trials have focused on specific targets to redirect the immune network toward eradicating a variety of tumors and ameliorating the self-destructive process. In a previous review, both s...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4032988/ https://ncbi.nlm.nih.gov/pubmed/24904570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2014.00206 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|